Devauchelle-Pensec et al. SEMAPHORE RCT- tocilizumab in refractory PMR. TCZ treated GC dependent patients - better disease activity, reduced GC, less flare, more frequent GC-free remission @RheumNow #ACR22 Abstr#1106 https://t.co/UevgjF8di5 https://t.co/GmXqasNscp
Links:
Effect of Tocilizumab on Disease Activity in Patients with Active Polymyalgia R…
https://acrabstracts.org/abstract/effect-of-tocilizumab-on-disease-activity-in-…
13-11-2022
